# Cellular Interactions and Competition in Clonal Hematopoiesis

> **NIH NIH F30** · BAYLOR COLLEGE OF MEDICINE · 2024 · $49,821

## Abstract

PROJECT SUMMARY
Clonal hematopoiesis (CH) is the expansion of peripheral blood cells derived from a single mutant
hematopoietic stem cell (HSC) in the absence of hematological malignancy. CH is associated with increased
risk of several age associated diseases however the disease manifestation and prognosis varies based on which
gene is mutated, the variant, and the mutational burden. Most individuals over the age of 55 have at least one
detectable clone, and of those, 25% have two or more mutant populations present. Despite this vast and variable
health burden, little is known about how interactions between mutant clones influences clonal expansion.
The top three genes mutated in CH are epigenetic modifiers DNA Methyltransferase 3A (Dnmt3a), Ten-
Eleven Translocation Protein 2 (Tet2) and Additional Sex Comb like 1 (Asxl1). Several independent studies of
each mutant clone in isolation have identified that these mutations provide HSCs with a survival advantage over
wild type HSCs in the setting of inflammatory stressors, like infections. Additionally, these mutant clones not only
respond to inflammatory stimuli, but are also potent produces of pro-inflammatory cytokines that aids in creating
an environment that selects for the survival of the mutant clone. Transcriptionally, CH clones have a mutation-
specific resistance to extinction by either attenuating the inflammatory stress response or preventing terminal
differentiation. Collectively, these studies suggest Dnmt3a, Asxl1 and Tet2 deficient clones have a mutation-
specific resistance to inflammatory pressures, and they perpetuate this selective advantage by inducing pro-
inflammatory states. These studies also suggest that mutant clones and their progeny may impact the expansion
of neighboring clones, but such clonal interactions and competition has not been studied.
 Preliminary experiments show Tet2 mutant clonal expansion is impaired when in the presence of Asxl1 and
Dnmt3a-mutant cells. Interestingly, Asxl1 mutant clonal expansion is unaffected by other mutant clones and
remains consistent with the presence or absence of other mutant clones. This unexpected finding suggests
unexplored interactions between clones having a mutation-specific effect on clonal expansion. Based on
published and preliminary data, I hypothesize that mutations influence the inflammatory microenvironment as
well as the transcriptional response to stimuli such that clones behave differently in the presence or absence of
other clones. In Aim 1, I will characterize clonal competition by measuring clonal expansion of Dnmt3a, Asxl1
and Tet2 deficient clones when in the presence and absence of other mutant clones following inflammatory
challenge. In Aim 2, I will utilize single cell RNA sequence and ex vivo culturing experiments to identify
interactions underlying clonal expansion between Dnmt3a, Asxl1 and Tet2 deficient HSCs and downstream
immune cells. With the successful completion of these aims, I will be able to char...

## Key facts

- **NIH application ID:** 10998269
- **Project number:** 1F30HL172468-01A1
- **Recipient organization:** BAYLOR COLLEGE OF MEDICINE
- **Principal Investigator:** Apoorva Thatavarty
- **Activity code:** F30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $49,821
- **Award type:** 1
- **Project period:** 2024-12-01 → 2026-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10998269

## Citation

> US National Institutes of Health, RePORTER application 10998269, Cellular Interactions and Competition in Clonal Hematopoiesis (1F30HL172468-01A1). Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/grant/nih/10998269. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*